Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Issue of Equity

5 Apr 2024 15:49

RNS Number : 5598J
Maven Income and Growth VCT 5 PLC
05 April 2024
Β 

Maven Income and Growth VCT 5 PLC (the Company)

Β 

Issue of Equity

Β 

On 13 October 2023, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to Β£5 million, with an over-allotment facility for up to a further Β£2.5 million (the Offer).

Β 

Pursuant to the Offer, a total of Β£2,338,474 of valid applications were received in the period from 9.00am on 21 March 2024 up to and including 9.00am on 5 April 2024 in respect of the 2023/2024 tax year. This is the final allotment in respect of the 2023/2024 tax year and, as a result, the Company has issued and allotted 7,209,045 new Ordinary Shares on 5 April 2024. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 31.52p to 32.36p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 211,914,797. Therefore, the total number of voting rights in the Company is 211,914,797. The total amount raised by the Company for the 2023/2024 tax year to 5 April 2024 is Β£6,262,885.

Β 

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective, and dealings will commence, on or around 8 April 2024.

Β 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

The Board of the Company intends that an allotment in respect of applications for the 2024/2025 tax year will take place on, or around, 1 May 2024. For this allotment, and those made to date, the Company's Offer has received applications totalling Β£6,554,185.

Β 

For further information, please contact:

Β 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Β 

Maven Capital Partners UK LLP

Secretary

Β 

5 April 2024

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEQKPBQQBKDOQK
Date   Source Headline
16th Apr 201411:49 amRNSDirector Declaration
7th Apr 20144:19 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:32 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
3rd Mar 20144:13 pmRNSAnnual Financial Report
13th Feb 201410:57 amRNSDirector/PDMR Shareholding
13th Feb 201410:55 amRNSDirector/PDMR Shareholding
13th Feb 201410:47 amRNSDirector/PDMR Shareholding
10th Feb 20146:04 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:22 pmRNSIssue of Equity
3rd Feb 20145:23 pmRNSStatement re NAV and Offer for Subscription (Repla
27th Jan 20145:00 pmRNSStatement re NAV, Dividend and Offer
27th Nov 20132:07 pmRNSResult of General Meeting
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20135:10 pmRNSTransaction in Own Shares
11th Oct 20135:12 pmRNSInterim Management Statement
11th Oct 201312:18 pmRNSDirectorate Change
10th Oct 201311:02 amRNSNet Asset Value(s)
9th Oct 201311:09 amRNSNet Asset Value(s)
8th Oct 20131:49 pmRNSNet Asset Value(s)
7th Oct 201312:35 pmRNSNet Asset Value(s)
4th Oct 20132:12 pmRNSNet Asset Value(s)
3rd Oct 20132:36 pmRNSNet Asset Value(s)
2nd Oct 201312:21 pmRNSNet Asset Value(s)
1st Oct 201312:27 pmRNSNet Asset Value(s)
30th Sep 20132:43 pmRNSNet Asset Value(s)
27th Sep 201312:04 pmRNSNet Asset Value(s)
26th Sep 201311:57 amRNSNet Asset Value(s)
25th Sep 201312:22 pmRNSNet Asset Value(s)
25th Sep 201311:39 amRNSStatement re Proposed Joint Fund Raising
24th Sep 201311:52 amRNSNet Asset Value(s)
23rd Sep 201311:47 amRNSNet Asset Value(s)
20th Sep 20132:15 pmRNSNet Asset Value(s)
19th Sep 20131:05 pmRNSNet Asset Value(s)
18th Sep 201310:16 amRNSNet Asset Value(s)
17th Sep 201310:38 amRNSNet Asset Value(s)
16th Sep 201311:35 amRNSNet Asset Value(s)
13th Sep 201311:25 amRNSNet Asset Value(s)
12th Sep 201311:09 amRNSNet Asset Value(s)
11th Sep 201312:26 pmRNSNet Asset Value(s)
10th Sep 201312:22 pmRNSNet Asset Value(s)
9th Sep 20131:41 pmRNSNet Asset Value(s)
6th Sep 201311:44 amRNSNet Asset Value(s)
5th Sep 20131:14 pmRNSDirector Declaration
5th Sep 201312:33 pmRNSNet Asset Value(s)
4th Sep 20131:37 pmRNSNet Asset Value(s)
3rd Sep 201310:50 amRNSNet Asset Value(s)
2nd Sep 201311:17 amRNSNet Asset Value(s)
30th Aug 201312:30 pmRNSNet Asset Value(s)
29th Aug 201310:56 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.